This site is intended only for the use of UK Healthcare Professionals

Managing faltering growth with an Amino Acid Formula (AAF)

Cows' Milk Allergy

31/03/2021

Mother Sitting With Child On Bed Smiling

Approximately 2-7.5% of infants have symptoms of CMA¹ whilst symptoms suggestive of Cows’ Milk Allergy (CMA) may be encountered in up to 15% of infants, emphasising the importance of controlled elimination/milk challenge procedures². The diagnosis and treatment pathways for cases of CMA are well documented and several guidelines exist to support the healthcare professional in successfully diagnosing and treating infants with CMA^3-8. The role of Amino Acid formulas in severe cases of CMA has been shown to be beneficial and to help improve quality of life^9,10.

Patient’s background/medical history/physical/diagnosis

Visit 1

Early in 2014, a 7 month old baby girl presented at RMCH with treatment resistant atopic dermatitis (eczema) and concomitant gastric oesophageal reflux, for which she was on anti reflux medication. The patient’s weight was 6.3kg and she was on the 9th percentile. The patient’s family history was taken and allergy atopy was identified, as well as a zinc deficiency and skin infections for which antibiotics had been prescribed.

The baby was being breast fed by her mother who had tried eliminating wheat and dairy from her diet, as the patient’s older sibling had a wheat allergy.

Interventions

The mother was given strict dairy avoidance dietary advice and was asked to take calcium and vitamin D supplements. The patient’s anti reflux medications were increased. Breast feeding continued and the infant was given zinc supplements. Advice was given to continue dairy product elimination through weaning.

Visit 2

3 months later the patient re-presented with sever discoid eczema and food associated enterocolitis. She was diagnosed with a severe non IgE mediated food allergy. Her weight had not increased significantly

(6.62kg) and she was now between the 0.4th and the 2nd percentile, now faltering in growth with zinc and vitamin D deficiency. Her mother was still breast feeding and was now avoiding eggs, dairy products, wheat and nuts. The patient had episodes of loose stools, although her reflux was settling.

The patient was not sleeping due to the itchiness of the skin and was admitted to the ward directly from the clinic.

Feeding with an amino acid based formula (Alfamino®, Nestlé Health Science) was initially via a nasogastric tube. This was started with a target volume of 120 ml/kg, every 3 hours (6-7 feeds per day). After intervention from the play therapist bottle feeding was able to commence after 24 hours.

Results

Within 3 days the child was sleeping better and the eczema on her face and body was beginning to settle.

She was discharged from the ward with zinc and vitamin D supplements and Alfamino® formula.

After 1 month the patient was reviewed. She had gained 1.1kg in weight (just under the 25th percentile) and the eczema had improved considerably with a reduction in itchiness, redness and inflammation. Her mother noticed she was also sleeping better. Odd bouts of diarrhoea still occurred but the reflux had resolved and medications had been stopped. Weaning was in progress with the reintroduction of low atopic risk foods. She continued with the amino acid formula.

Discussion

Upon reflection this young infant who was sensitive to breast milk and had faltering growth responded well to an amino acid formula. Due to her symptoms presented in clinic, it was not appropriate to use an extensively hydrolysed formula (eHF) as she had experienced a drop in growth centile and there was a risk she would not respond to an eHF based on her clinical history. Alfamino® was chosen for palatability reasons (a blind tasting had been conducted in the department between all available formulas) and because of the high MCT content (24.4% of total fat) to help with loose stools. Severe symptoms of CMA can cause high levels of stress and anxiety and this patient and her family had significant reductions in quality of life as a result. The patient’s mother was desperate for help to get her daughter back on track.

Conclusions

Amino acid formulas have an important role to play in the treatment of severe cows’ milk allergy symptoms. Alfamino® was well tolerated and palatable, helping to improve quality of life and has been a successful choice of formula for this baby with severe faltering growth.

References: 1. Ludman et al. BMJ 2013; 247:F5424. 2. Host. Ann Allergy Astma Immunol. 2002; 89:33-37.(2002). 3. CEA. 4. COACI

5. ESPGHAN 6. DRACMA 7. VENTER et al 8. NICE 2011 9. Vanderplas et al Arch Dis Child 2007; 92:902 - 908. 10. Niggemann B, Binder C, Dupont C, Hadji S, Arvola T, Isolauri E: Prospective, controlled, multi-center study on the effect of an amino-acid-based formula in infants with cow’s milk allergy/intolerance and atopic dermatitis. Pediatr Allergy Immunol 2001, 12(2):78–82.

IMPORTANT NOTICE: Mothers should be encouraged to continue breastfeeding even when their infants have cows’ milk protein allergy. This usually requires qualified dietary counselling to completely exclude all sources of cows’ milk protein from the mothers’ diet. If a decision to use a special formula intended for infants is taken, it is important to give instructions on correct preparation methods, emphasising that unboiled water, unsterilised bottles or incorrect dilution can all lead to illness. Formula for special medical purposes intended for infants must be used under medical supervision.

" THE USE OF AMINO ACID FORMULA IN THE DIETARY MANAGEMENT OF SEVERE INFANT COWS’ MILK ALLERGY Approximately 2-7.5% of infants have symptoms of CMA1 whilst symptoms suggestive of Cows’ Milk Allergy (CMA) may be encountered in up to 15% of infants, emphasising the importance of controlled elimination/milk challenge procedures2. The diagnosis and treatment pathways for cases of CMA are well documented and several guidelines exist to support the healthcare professional in..."

Other content you might be interested in

The Benefits of Human Milk Oligosaccharides (HMO) on Immunity

Human milk contains bioactive components that confer protection on the newborn. These include complex carbohydrates called Human Milk Oligosaccharides (HMO). Research is revealing the full extent of the beneficial properties of HMOs.

Human Milk Oligosaccharides (HMO)

HMOs, the third solid component of human milk, are complex structures with a high potential for specific functions. HMOs and prebiotic oligosaccharides have completely different structures, which impact on their functions. Additionally to prebiotic effects, HMOs reduces adhesion of pathogens and have immune modulator effect.

Cows’ Milk Allergy Weaning Guide

The weaning guide contains recipes developed with leading dietitians from across the UK to help your patients' carers prepare milk-free recipes. The weaning guide can help give them confidence, that as their child grows, family meals can be adapted to make them suitable for CMA.

Evaluation of hypoallergenicity of a new, amino-acid based formula

Cows’ milk allergy (CMA) is one of the major food allergies during infancy and childhood. Hypoallergenic formulas can be necessary for managing infants and children with severe CMA. According to the American Academy of Pediatrics (AAP), a formula is “hypoallergenic” if it does not provoke allergenic activity in 90% of infants or children with confirmed CMA with 95% confid...

What do we know about lactose?

There is much confusion between the diagnostic terms ‘lactose intolerance’ and ‘cows’ milk allergy’, which are often used interchangeably, resulting in the potentially incorrect clinical management of these two distinct conditions.

A practical approach to managing a CMA infant with an extensively hydrolysed formula

A practical approach to managing a CMA infant with Althera™ Cows’ Milk Allergy (CMA) can occur in 1.8% - 7.5% of infants in the first year of life.1 The allergy is defined as an adverse reaction to the proteins in milk with most children growing out of their allergy by the time they reach one year. The treatment consists of the exclusion of cows’ milk from the infant’s diet. There...

Twins with cows’ milk allergy step down from AAF to EHF

16 weeks old, female twins were identified on EMIS search at a GP practise by an Oviva community dietitian for review. They were not already under the care of a dietitian and had both been started on Neocate LCP® for suspected cows’ milk allergy (CMA) at 6 weeks old by a paediatrician. The dietitian successfully switched both twins to SMA Alfamino and later stepped them down to SMA Althera.

Managing CMA with an Amino Acid Formula (AAF)

" MANAGING COWS’ MILK PROTEIN ALLERGY WITH ALFAMINO® Overview of cows’ milk protein allergy in infants Cows’ milk protein allergy (CMPA) is one of the most common food allergies in infants.1 Symptoms of CMPA include : Gastrointestinal (32-60% cases) Skin (5-90%) Anaphylaxis (0.8-9%) Respiratory Many of these symptoms overlap. CMPA can be classified into two groups: IgE mediated or non-IgE mediated (delayed hypersensitiv..."

Towards Optimised Management of Cow’s Milk Protein Allergy

This symposium took place during the 2018 meeting of the European Academy of Allergy and Clinical Immunology (EAACI). Focussing on the fundamental issues of suboptimal management of patients with cow’s milk protein allergy (CMPA), the speakers discussed key themes for optimising management.

The importance of having a choice of eHF and AAF milks in the management of CMA

During the last decade, the prevalence of allergic diseases in infants and children has increased significantly either through better awareness of the symptoms or through generally more children being affected.1-3 Therefore, it is no surprise that the numbers of children presenting to clinics in district general hospitals has also increased.4-5 Diagnosis of true milk allergy is key...

Human Milk Oligosaccharides: New Ways to Shape the Gut Microbiome in Cows’ Milk Protein Allergy

Prof O’Mahony began by discussing how the human gut is colonised by a wide diversity of microbes. He went on to review the evidence for how they exhibit highly evolved synergistic relationships to provide essential biological functions to the host and how the gut microbiome is influenced by many factors in early life. Prof Renz proceeded to describe the importance of establishing a s..

Safety and Efficacy of a new extensively hydrolyzed formula for infants with Cows’ Milk protein allergy

Cows’ milk protein allergy (CMPA) is the leading cause of allergy in infants. Previous studies assessing milk formulas with extensively hydrolyzed proteins have reported issues such as reactivity to residual allergens, bitter taste, and the impracticability of adding lactose.